hemophilia A and B gene therapy (ALG)

N/A

Report date: 2026/01/27 10:14:00

Base Information

Drug Namehemophilia A and B gene therapy (ALG)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHemophilia BHemophilia A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesALG Co
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesALG Co
Active IndicationsN/A
Inactive IndicationsHemophilia BHemophilia A

Other Information

ATC CodeN/A
Related LinksN/A